Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Restructuring (2016 - 2018)

Historic Cash from Restructuring for Fresenius Medical Care AG (FMS) over the last 6 years, with Q4 2018 value amounting to $51.4 million.

  • Fresenius Medical Care AG's Cash from Restructuring fell 1446.52% to $51.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $51.4 million, marking a year-over-year decrease of 1446.52%. This contributed to the annual value of $53.2 million for FY2018, which is 770.19% down from last year.
  • Latest data reveals that Fresenius Medical Care AG reported Cash from Restructuring of $51.4 million as of Q4 2018, which was down 1446.52% from $59.7 million recorded in Q2 2018.
  • Fresenius Medical Care AG's Cash from Restructuring's 5-year high stood at $70.2 million during Q4 2016, with a 5-year trough of $51.4 million in Q4 2018.
  • Moreover, its 3-year median value for Cash from Restructuring was $60.0 million (2017), whereas its average is $60.9 million.
  • In the last 5 years, Fresenius Medical Care AG's Cash from Restructuring crashed by 1443.82% in 2017 and then plummeted by 1446.52% in 2018.
  • Fresenius Medical Care AG's Cash from Restructuring (Quarter) stood at $70.2 million in 2016, then decreased by 14.44% to $60.0 million in 2017, then dropped by 14.47% to $51.4 million in 2018.
  • Its Cash from Restructuring stands at $51.4 million for Q4 2018, versus $59.7 million for Q2 2018 and $60.0 million for Q4 2017.